ATE210677T1 - Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung - Google Patents

Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung

Info

Publication number: ATE210677T1
Authority: AT; Austria
Prior art keywords: analogues; angiotensin iii; tissue healing; wound healing; analogs
Prior art date: 1993-09-24

Application number

AT94928150T

Other languages

English (en)

Inventor

Kathleen Elizabeth Rodgers

Gere Stodder Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-19

Publication date

2001-12-15

1994-09-19 Application filed by Univ Southern California filed Critical Univ Southern California

2001-12-15 Application granted granted Critical

2001-12-15 Publication of ATE210677T1 publication Critical patent/ATE210677T1/de

Links

QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 title abstract 2
101800000738 Angiotensin-3 Proteins 0.000 title abstract 2
102400000348 Angiotensin-3 Human genes 0.000 title abstract 2
230000035876 healing Effects 0.000 title 1
230000029663 wound healing Effects 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Immunology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

AT94928150T 1993-09-24 1994-09-19 Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung ATE210677T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12636893A	1993-09-24	1993-09-24
PCT/US1994/010503 WO1995008337A1 (en)	1993-09-24	1994-09-19	Use of angiotensin iii and analogs thereof in tissue repair

Publications (1)

Publication Number	Publication Date
ATE210677T1 true ATE210677T1 (de)	2001-12-15

Family

ID=22424455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94928150T ATE210677T1 (de)	1993-09-24	1994-09-19	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung

Country Status (13)

Country	Link
US (1)	US5629292A (de)
EP (1)	EP0730465B1 (de)
JP (1)	JPH09502977A (de)
AT (1)	ATE210677T1 (de)
AU (1)	AU706333B2 (de)
CA (1)	CA2172493C (de)
DE (1)	DE69429450T2 (de)
DK (1)	DK0730465T3 (de)
ES (1)	ES2168312T3 (de)
PT (1)	PT730465E (de)
TW (1)	TW311088B (de)
WO (1)	WO1995008337A1 (de)
ZA (1)	ZA947338B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955430A (en)	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
MY121607A (en) *	1995-07-10	2006-02-28	Hyundai Curitel Inc	Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
EP1410801B1 (de)	1997-01-28	2013-04-10	University Of Southern California	Verfahren zur Förderung der hämatopoietischen Zellproliferation und Differenzierung
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) *	1997-02-04	1998-08-06	University Of Southern California	Method for accelerating healing of thermal injuries
US6197751B1 (en)	1997-11-10	2001-03-06	The United States Of America As Represented By The Department Of Health And Human Services	Thymosin α1 promotes tissue repair, angiogenesis and cell migration
AU1706399A (en) *	1997-11-26	1999-06-15	University Of Southern California	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
DE69824445T2 (de)	1997-12-12	2005-06-30	University Of Southern California, Los Angeles	Zusammensetzungen zur wundheilung
EP1053004A2 (de)	1998-02-09	2000-11-22	University Of Southern California	Verwendung von angiotensin-analoga zur forderung der erythropoiesis
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
AU3077299A (en)	1998-03-11	1999-09-27	University Of Southern California	Method of promoting production of living tissue equivalents
AU752041B2 (en) *	1998-04-09	2002-09-05	University Of Southern California	Methods for treatment and prevention of infections
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6475988B1 (en)	1998-05-11	2002-11-05	University Of Southern California	Methods to increase white blood cell survival after chemotherapy
US6916783B2 (en) *	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
US6258778B1 (en)	1998-07-13	2001-07-10	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
AU755943B2 (en) *	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue
DK1035133T3 (da)	1999-02-17	2005-05-02	Pfizer Prod Inc	Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
EP1345602B1 (de) *	2000-11-30	2010-07-21	Novodermix International Limited	Heilung von wunden
AU2002308522A1 (en) *	2001-05-01	2002-11-11	University Of Southern California	Methods for inhibiting tumor cell proliferation
KR20100056508A (ko) *	2007-09-11	2010-05-27	몬도바이오테크 래보래토리즈 아게	폐렴 연쇄상 구균 감염의 치료를 위한 ｂｆｇｆ１－２４ 및 임의의 （ａｒｇ８）바소프레신의 용도
WO2009033820A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
WO2009033730A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratoires Ag	Peptide gxgrgdspca as a therapeutic agent
JP2010538979A (ja) *	2007-09-11	2010-12-16	モンドバイオテックラボラトリーズアクチエンゲゼルシャフト	Ｓ．Ｐｎｅｕｍｏｎｉａｅの感染等を処置するための治療剤としての、ＲＧＤＳＰＡＳＳＫＰ、および随意的なアンギオテンシンＩＩの使用
WO2009040051A2 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent
WO2009114461A2 (en) *	2008-03-10	2009-09-17	University Of Southern California	Angiotensin (1-7) dosage forms and uses thereof
HRP20151440T1 (hr)	2008-12-29	2016-01-29	Trevena, Inc.	Efektori beta-arestina i sastavi i metode u kojima se koriste
CN102858360B (zh)	2011-02-02	2017-07-25	南加利福尼亚大学	治疗糖尿病足溃疡的方法
AU2013215269A1 (en)	2012-01-31	2014-08-21	Trevena, Inc.	Beta-arrestin effectors and compositions and methods of use thereof
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
JP6254692B2 (ja)	2013-07-03	2017-12-27	ジアリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	認知機能不全を治療するための方法
US9518086B2 (en)	2014-02-07	2016-12-13	Trevena, Inc.	Crystalline and amorphous forms of a β-arrestin effector
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
US9611293B2 (en)	2014-05-19	2017-04-04	Trevena, Inc.	Synthesis of beta-arrestin effectors
JP6666899B2 (ja)	2014-07-21	2020-03-18	アリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	Ａｎｇ−（１−７）誘導体オリゴペプチド、ならびにそれを使用および作製するための方法
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
WO2017066552A1 (en) *	2015-10-14	2017-04-20	Tarix Pharmaceuticals Ltd.	Methods and compositions for the treatment of epidermolysis bullosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886134A (en) *	1970-03-09	1975-05-27	Morton Norwich Products Inc	Analogues of angiotensin II
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-19 EP EP94928150A patent/EP0730465B1/de not_active Expired - Lifetime
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en not_active Ceased
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
TW311088B (de)	1997-07-21
WO1995008337A1 (en)	1995-03-30
CA2172493C (en)	2003-09-16
DE69429450T2 (de)	2002-07-25
AU706333B2 (en)	1999-06-17
CA2172493A1 (en)	1995-03-30
DK0730465T3 (da)	2002-04-08
ES2168312T3 (es)	2002-06-16
AU7730294A (en)	1995-04-10
DE69429450D1 (de)	2002-01-24
EP0730465B1 (de)	2001-12-12
US5629292A (en)	1997-05-13
PT730465E (pt)	2002-06-28
EP0730465A1 (de)	1996-09-11
ZA947338B (en)	1995-05-10
EP0730465A4 (de)	1997-11-12
JPH09502977A (ja)	1997-03-25

Legal Events

Date	Code	Title	Description
2006-06-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE210677T1 (de)	2001-12-15	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69435301D1 (de)	2010-08-26	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
ATE309775T1 (de)	2005-12-15	Die verwendung von prostaglandin f analoga zur herstellung von zusammensetzungen für die behandlung von haarausfall.
ATE393831T1 (de)	2008-05-15	Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE69430440D1 (de)	2002-05-23	Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
ATE186840T1 (de)	1999-12-15	Zusammensetzungen und methoden zur wundbehandlung
FI971536A0 (fi)	1997-04-11	Keratinosyytti-kasvutekijän analogeja
AR003641A1 (es)	1998-08-05	Composiciones y metodos para controlar los hongos perjudiciales.
DE69827001D1 (de)	2004-11-18	Gewebedezellularization
AR018357A1 (es)	2001-11-14	Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
BR9507730A (pt)	1997-09-23	Uso de formulações em gel como composições de tratamento
DE69535976D1 (de)	2009-08-13	Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor
DE69510775D1 (de)	1999-08-19	Methoden zur verwendung von cyclischenpolyanionischen polyderivatenzur kontrolle von hautfalten
ES2221950T3 (es)	2005-01-16	Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
ES2088128T3 (es)	1996-08-01	Aminosulfonilureas inhibidoras de acat.
ES2134237T3 (es)	1999-10-01	Composiciones farmaceuticas que contienen acido ursodesoxicolico.
NO2019032I1 (no)	2019-07-23	Treosulfan
DK0613368T3 (da)	1998-01-26	Hudregenererende kosmetisk sammensætning
FR2720938B1 (fr)	1996-08-30	Composition dermato-cosmétologique et son utilisation.
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
DE69931148D1 (de)	2006-06-08	Behandlung von hiv infektionen
ES2065308T1 (es)	1995-02-16	Producto para el moldeado permanente del cabello y nuevos esteres de acido 2-hidroxi-3-mercaptopropionico reductores de la queratina capilar.
EA199800953A1 (ru)	1999-04-29	Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
MX9705592A (es)	1997-11-29	Composiciones farmaceuticas que contienen corticosteroides y preparacion de las mismas.